HSA
NVO

Hussman Strategic Advisors’s Novo Nordisk NVO Stock Holding History

Hussman Strategic Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,000
Closed -$2.33M – 331
2025
Q3 		$2.33M Sell
42,000
-10,500
-20% -$615K 0.5% 68
2025
Q2 		$3.62M Sell
52,500
-10,500
-17% -$714K 0.83% 28
2025
Q1 		$4.37M Hold
63,000
– – 1.06% 10
2024
Q4 		$5.42M Buy
63,000
+12,600
+25% +$1.36M 1.6% 4
2024
Q3 		$6M Buy
50,400
+8,400
+20% +$1.12M 1.47% 6
2024
Q2 		$6M Buy
42,000
+10,500
+33% +$1.39M 1.65% 1
2024
Q1 		$4.04M Buy
+31,500
New +$3.75M 0.94% 25

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hussman Strategic Advisors's NVO Position: Q4 2025 in Review

Hussman Strategic Advisors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 42,000 shares — an estimated $2.33M sold.

Hussman Strategic Advisors first reported a position in NVO in Q1 2024 and held it in 7 quarters. The position peaked at $6M in Q3 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Hussman Strategic Advisors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 42,000 Novo Nordisk shares in Q4 2025, an estimated $2.33M.
  • Hussman Strategic Advisors first reported a position in Novo Nordisk in Q1 2024 and held it in 7 quarters.
  • Hussman Strategic Advisors's Novo Nordisk position peaked at $6M in Q3 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Hussman Strategic Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.